Literature DB >> 18255009

Obesity, diabetes, and chronic kidney disease.

Garabed Eknoyan1.   

Abstract

Similar to diabetes, obesity is associated with the early onset of glomerulomegaly, hemodynamic changes of a hyperfiltering kidney, and increased albuminuria, which are potentially reversible with weight loss. However, the pathologic lesions of focal segmental glomerulosclerosis in experimental models of sustained obesity, and in obese humans presenting with massive proteinuria, are different from those of classic diabetic nephropathy. In addition, several observational, cross-sectional, and longitudinal studies document obesity as an independent risk factor for the onset, aggravated course, and poor outcomes of chronic kidney disease, even after adjustment for confounding comorbidities, including diabetes and hypertension, the two major causes of chronic kidney disease.

Entities:  

Mesh:

Year:  2007        PMID: 18255009     DOI: 10.1007/s11892-007-0076-5

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  45 in total

1.  Comparison in renal histology between Japanese obese and non-obese microalbuminuric type 2 diabetic patients.

Authors:  Masao Kanauchi
Journal:  Nephrol Dial Transplant       Date:  2003-04       Impact factor: 5.992

Review 2.  Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications.

Authors:  Pantelis A Sarafidis; Luis M Ruilope
Journal:  Am J Nephrol       Date:  2006-05-29       Impact factor: 3.754

3.  Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes.

Authors:  K A Kohler; W M McClellan; D C Ziemer; D G Kleinbaum; J R Boring
Journal:  Am J Kidney Dis       Date:  2000-11       Impact factor: 8.860

4.  Microalbuminuria in obese patients with or without hypertension.

Authors:  P Valensi; M Assayag; M Busby; J Pariès; B Lormeau; J R Attali
Journal:  Int J Obes Relat Metab Disord       Date:  1996-06

5.  Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis.

Authors:  M Praga; E Hernández; E Morales; A P Campos; M A Valero; M A Martínez; M León
Journal:  Nephrol Dial Transplant       Date:  2001-09       Impact factor: 5.992

6.  Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy.

Authors:  M Praga; E Hernández; J C Herrero; E Morales; Y Revilla; R Díaz-González; J L Rodicio
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

7.  Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments].

Authors:  G Wolf; A Hamann; D C Han; U Helmchen; F Thaiss; F N Ziyadeh; R A Stahl
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

8.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

Review 9.  Survival advantages of obesity in dialysis patients.

Authors:  Kamyar Kalantar-Zadeh; Kevin C Abbott; Abdulla K Salahudeen; Ryan D Kilpatrick; Tamara B Horwich
Journal:  Am J Clin Nutr       Date:  2005-03       Impact factor: 7.045

10.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Authors:  A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

View more
  23 in total

Review 1.  The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.

Authors:  Tina Thethi; Masumi Kamiyama; Hiroyuki Kobori
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

2.  The Presence and Location of Podocytes in Glomeruli as Affected by Diabetes Mellitus.

Authors:  Kathryn E Maraszek; Briana A Santo; Rabi Yacoub; John E Tomaszewski; Imtiaz Mohammad; Amber M Worral; Pinaki Sarder
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2020-03-16

Review 3.  Obesity and diabetic kidney disease.

Authors:  Christine Maric-Bilkan
Journal:  Med Clin North Am       Date:  2012-11-27       Impact factor: 5.456

4.  Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet-induced obesity.

Authors:  K A Jenkin; L O'Keefe; A C Simcocks; J F Briffa; M L Mathai; A J McAinch; D H Hryciw
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

5.  Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

Authors:  Tony Jourdan; Gergő Szanda; Avi Z Rosenberg; Joseph Tam; Brian James Earley; Grzegorz Godlewski; Resat Cinar; Ziyi Liu; Jie Liu; Cynthia Ju; Pál Pacher; George Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

Review 6.  Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus.

Authors:  George L Bakris
Journal:  Mayo Clin Proc       Date:  2011-05       Impact factor: 7.616

7.  Assessing natural direct and indirect effects for a continuous exposure and a dichotomous outcome.

Authors:  Wei Wang; Bo Zhang
Journal:  J Stat Theory Pract       Date:  2016-06-22

8.  Albuminuria in Patients with Morbid Obesity and the Effect of Weight Loss Following Bariatric Surgery.

Authors:  Johanna Maria Brix; Carsten Thilo Herz; Hans Peter Kopp; Astrid Feder; Eva-Christina Krzizek; Christoph Sperker; Gerit-Holger Schernthaner; Guntram Schernthaner; Bernhard Ludvik
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

9.  The Common FTO Genetic Polymorphism rs9939609 is Associated with Increased BMI in Type 1 Diabetes but not with Diabetic Nephropathy.

Authors:  Harvest F Gu; Alexandra Alvarsson; Kerstin Brismar
Journal:  Biomark Insights       Date:  2010-04-27

10.  Genomic insights into early-onset obesity.

Authors:  Hélène Choquet; David Meyre
Journal:  Genome Med       Date:  2010-06-23       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.